Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omega 3-6 in Children With Autism Spectrum Disorder
NCT04312932Phase 2Completed
- Start
- Dec 2021
- Primary completion
- Nov 2023
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Autism Spectrum Disorder (ASD) (2 arms). Primary endpoint: Pervasive Developmental Disorder Behavior Inventory - Autism Composite at 90 days. Started Dec 2021; status: completed.
02
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT04312932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04312932.